94 related articles for article (PubMed ID: 23998422)
1. Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Achiron A; Mashiach R; Zilkha-Falb R; Meijler MM; Gurevich M
J Neuroimmunol; 2013 Oct; 263(1-2):91-7. PubMed ID: 23998422
[TBL] [Abstract][Full Text] [Related]
2. Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis.
Zilkha-Falb R; Gurevich M; Achiron A
Neuromolecular Med; 2017 Sep; 19(2-3):406-412. PubMed ID: 28755038
[TBL] [Abstract][Full Text] [Related]
3. RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis.
Achiron A; Zilkha-Falb R; Mashiach R; Gurevich M
J Neuroimmunol; 2017 Jan; 302():41-48. PubMed ID: 27908532
[TBL] [Abstract][Full Text] [Related]
4. Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
Ozgun-Acar O; Celik-Turgut G; Gazioglu I; Kolak U; Ozbal S; Ergur BU; Arslan S; Sen A; Topcu G
J Neuroimmunol; 2016 Sep; 298():106-16. PubMed ID: 27609283
[TBL] [Abstract][Full Text] [Related]
5. RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice.
Zilkha-Falb R; Rachutin-Zalogin T; Cleaver L; Gurevich M; Achiron A
J Neuroinflammation; 2020 Oct; 17(1):313. PubMed ID: 33081798
[TBL] [Abstract][Full Text] [Related]
6. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ghazavi A; Mosayebi G
Phytother Res; 2012 Jan; 26(1):34-8. PubMed ID: 21538630
[TBL] [Abstract][Full Text] [Related]
8. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
9. Polymerase-1 pathway activation in acute multiple sclerosis relapse.
Achiron A; Zilkha-Falb R; Feldman A; Bovim M; Rozen O; Sarova-Pinhas I; Magalashvili D; Dolev M; Menascu S; Gurevich M
Autoimmun Rev; 2018 Dec; 17(12):1235-1239. PubMed ID: 30316990
[TBL] [Abstract][Full Text] [Related]
10. Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Aminian A; Noorbakhsh F; Ghazi-Khansari M; Kafami L; Javadi S; Hassanzadeh G; Rahimian R; Dehpour AR; Mehr SE
Neuroscience; 2013 Sep; 248():299-306. PubMed ID: 23774631
[TBL] [Abstract][Full Text] [Related]
11. In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
Kandagaddala LD; Kang MJ; Haque MM; Im HY; Seo JE; Chung BC; Jung BH; Patterson TA; Kwon OS
J Neurol Sci; 2012 Jul; 318(1-2):36-44. PubMed ID: 22554692
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Fontes LB; Dos Santos Dias D; de Carvalho LS; Mesquita HL; da Silva Reis L; Dias AT; Da Silva Filho AA; do Amaral Corrêa JO
J Pharm Pharmacol; 2014 Jun; 66(6):886-94. PubMed ID: 24447171
[TBL] [Abstract][Full Text] [Related]
13. Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis.
Lourbopoulos A; Grigoriadis N; Lagoudaki R; Touloumi O; Polyzoidou E; Mavromatis I; Tascos N; Breuer A; Ovadia H; Karussis D; Shohami E; Mechoulam R; Simeonidou C
Brain Res; 2011 May; 1390():126-41. PubMed ID: 21406188
[TBL] [Abstract][Full Text] [Related]
14. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Zhu D; Liu M; Yang Y; Ma L; Jiang Y; Zhou L; Huang Q; Pi R; Chen X
J Neurosci Res; 2014 Sep; 92(9):1217-26. PubMed ID: 24798871
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
[TBL] [Abstract][Full Text] [Related]
17. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.
Walter S; Gulbins E; Halmer R; Jahromi NH; Becker KA; Schottek A; Blatti C; Davies L; Schnoeder L; Bertsch T; Engelhardt B; Fassbender K
Neurosignals; 2019; 27(S1):20-31. PubMed ID: 31778303
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of experimental allergic encephalomyelitis in C57BL/6 mice by soy daidzein.
Razeghi Jahromi S; Arrefhosseini SR; Ghaemi A; Alizadeh A; Moradi Tabriz H; Togha M
Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):256-64. PubMed ID: 24659161
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.
Kennedy MK; Tan LJ; Dal Canto MC; Miller SD
J Immunol; 1990 Jul; 145(1):117-26. PubMed ID: 2358669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
